BGN has also been discovered as a progressive biomarker in the transition from normal colon mucosa to adenoma and adenocarcinoma in colon cancer,33 and it has been postulated as a potential prognosis biomarker for colon cancer43 and has been shown to regulate CRC cells functions.29 The gene discussed is BGN; the disease is colorectal carcinoma.